Fibulin-5 is involved in phlebosclerosis of major portal vein branches associated with elastic fiber deposition in idiopathic portal hypertension

Hepatology Research

Volumn 38, Issue 2, 2008, Pages 166-173

  Sato, Yasunori ^a   Sawada, Seiko ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Elastic fiber; Fibrillin 1; Fibulin 5; Idiopathic portal hypertension; Phlebosclerosis

Indexed keywords

FIBRILLIN 1; FIBULIN 5;

ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; ELASTIC FIBER; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; VASCULAR FIBROSIS; VASCULAR RESISTANCE;

EID: 38049097648     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00253.x     Document Type: Article

References (26)

1. Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 2001; 197: 65-76.
2. Nakanuma Y, Hoso M, Sasaki M et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28: 195-204.
3. Tsuneyama K, Ohba K, Zen Y et al. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 2003; 43: 55-61.
4. Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis 2002; 22: 59-72.
5. Midwood KS, Schwarzbauer JE. Elastic fibers: Building bridges between cells and their matrix. Curr Biol 2002; 12: R279-81.
6. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci 2002; 115: 2817-28.
7. Yanagisawa H, Davis EC, Starcher BC et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002; 415: 168-71.
8. Nakamura T, Lozano PR, Ikeda Y et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002; 415: 171-5.
9. Freeman LJ, Lomas A, Hodson N et al. Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. Biochem J 2005; 388: 1-5.
10. Sawada S, Sato Y, Aoyama H, Harada K, Nakanuma Y. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of Annuals of Pathological Autopsy Cases in Japan. J Gastroenterol Hepatol 2007; 22: 204-9.
11. Wang X, LeMaire SA, Chen L et al. Decreased expression of fibulin-5 correlates with reduced elastin in thoracic aortic dissection. Surgery 2005; 138: 352-9.
12. Kuang PP, Goldstein RH, Liu Y, Rishikof DC, Jean JC, Joyce-Brady M. Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1147-52.
13. Merklinger SL, Wagner RA, Spiekerkoetter E et al. Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circ Res 2005; 97: 596-604.
14. Markova D, Zou Y, Ringpfeil F et al. Genetic heterogeneity of cutis laxa: A heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet 2003; 72: 998-1004.
15. Sato Y, Sawada S, Kozaka K et al. Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension. Dig Dis Sci 2007; 52: 1987-94.
16. Bona C, Saito S. Fibrillin-1 protein in tight skin mice and scleroderma. Clin Rev Allergy Immunol 2000; 18: 119-26.
17. Wallis DD, Tan FK, Kielty CM, Kimball MD, Arnett FC, Milewicz DM. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma). Arthritis Rheum 2001; 44: 1855-64.
18. Tan FK, Arnett FC, Antohi S et al. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol 1999; 163: 1066-72.
19. Tsuneyama K, Harada K, Katayanagi K et al. Overlap of idiopathic portal hypertension and scleroderma: Report of two autopsy cases and a review of literature. J Gastroenterol Hepatol 2002; 17: 217-23.
20. Dubuisson L, Lepreux S, Bioulac-Sage P et al. Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol 2001; 34: 514-22.
21. Lorena D, Darby IA, Reinhardt DP, Sapin V, Rosenbaum J, Desmouliere A. Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: Modulation by mechanical stress and role in cell adhesion. Lab Invest 2004; 84: 203-12.
22. Nakamura T, Ruiz-Lozano P, Lindner V etal. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 1999; 274: 22476-83.
23. Kowal RC, Richardson JA, Miano JM, Olson EN. EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ Res 1999; 84: 1166-76.
24. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 2002; 277: 27367-77.
25. Kadoya K, Sasaki T, Kostka G et al. Fibulin-5 deposition in human skin: decrease with ageing and ultraviolet B exposure and increase in solar elastosis. Br J Dermatol 2005; 153: 607-12.
26. Tsuneyama K, Kouda W, Nakanuma Y. Portal and parenchymal alterations of the liver in idiopathic portal hypertension: A histological and immunochemical study. Pathol Res Pract 2002; 198: 597-603.